Literature DB >> 230203

EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages.

J M Edwards, M Woodroof.   

Abstract

The following sera were tested for EB virus-specific IgA: serial sera from 61 cases of infectious mononucleosis (IM) and from 195 EBV IgG positive healthy students; single sera from each of 1469 persons of different ages, 63 cases of untreated Hodgkin's disease, and 22 neonates. EBV specific IgA was found in the sera from 88% of cases of IM, from 18.5% of EBV IgG positive healthy students, and in 13.5% of repeat samples from the same students three years later. The incidence of EBV IgA varied from 5 to 30% at different ages in single sera from EBV IgG positive persons aged 2 to 70 years. The higher percentages occurred in the age groups where recent sero-conversion rates were high. Fifteen percent of sera from cases of Hodgkin's disease were positive for EBV IgA, an incidence similar to that for healthy adults in the age group 25-45 years. None of the EBV IgG positive sera from neonates gave a positive reaction for EBV IGA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230203      PMCID: PMC1145887          DOI: 10.1136/jcp.32.10.1036

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.

Authors:  G Henle; W Henle
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

2.  Measurement of heterophil antibody and antibodies to EB viral capsid antigen IgG and IgM in suspected cases of infectious mononucleosis.

Authors:  J M Blake; J M Edwards; W Fletcher; D A McSwiggan; M S Pereira
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

3.  Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.

Authors:  G Miller; J C Niederman; L L Andrews
Journal:  N Engl J Med       Date:  1973-02-01       Impact factor: 91.245

4.  The use of cord serum and indirect viral immunofluorescence as a method of evaluating the immunological specificity of fluorescein-labelled anti-human IgA conjugate.

Authors:  H Mawhinney; M Haire; B M Adair
Journal:  J Immunol Methods       Date:  1973-04       Impact factor: 2.303

5.  Studies on the diagnostic value of an immunofluorescence test for EB virus-specific IgM.

Authors:  J M Edwards; D A McSwiggan
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

6.  Serum IgA antibodies to Epstein-Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma.

Authors:  H C Ho; H C Kwan; M H Ng; G de The
Journal:  Lancet       Date:  1978-02-25       Impact factor: 79.321

7.  Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience.

Authors:  N Rosdahl; S O Larsen; J Clemmesen
Journal:  Br Med J       Date:  1974-05-04

8.  Epstein-Barr virus infection in the neonatal period and in childhood.

Authors:  J Joncas; J Boucher; M Granger-Julien; C Filion
Journal:  Can Med Assoc J       Date:  1974-01-05       Impact factor: 8.262

9.  Infectious mononucleosis and Hodgkin's disease.

Authors:  N Muñoz; R J Davidson; B Witthoff; J E Ericsson; G De-Thé
Journal:  Int J Cancer       Date:  1978-07-15       Impact factor: 7.396

10.  Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.

Authors:  H C Ho; M H Ng; H C Kwan; J C Chau
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  4 in total

1.  An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections.

Authors:  R Cevenini; M Donati; F Rumpianesi; A Moroni; P Paolucci
Journal:  J Clin Pathol       Date:  1984-04       Impact factor: 3.411

2.  Rheumatoid arthritis, juvenile arthritis, iridocyclitis and the Epstein-Barr virus.

Authors:  A J Gear; P J Venables; J M Edwards; R N Maini; B M Ansell
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

3.  Effects of cyclosporin A on immunoglobulin production by EB virus stimulated lymphocytes.

Authors:  R S Pereira; A J Gear; C J Doré; A D Webster
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

4.  Epstein-Barr virus association with peptic ulcer disease.

Authors:  María G Cárdenas-Mondragón; Javier Torres; Lourdes Flores-Luna; Ricardo Carreón-Talavera; Margarita Camorlinga-Ponce; Ezequiel M Fuentes-Pananá
Journal:  Anal Cell Pathol (Amst)       Date:  2015-06-24       Impact factor: 2.916

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.